AAAAAA
Results:
1-13
|
Results: 13
Authors:
Isago, T
Morino, A
Kawai, S
Nagami, N
Sato, S
Ishitsu, H
Citation: T. Isago et al., Preparation and characterization of a SnO2/TiO2 bilayer thin film photocatalyst, J CERAM S J, 109(9), 2001, pp. 789-792
Authors:
Ogawa, T
Furuta, H
Takahashi, M
Morino, A
Uno, H
Citation: T. Ogawa et al., Synthesis and characterization of N-confused porphyrinatoantimony(V): toward a low energy gap molecular wire, J ORGMET CH, 611(1-2), 2000, pp. 551-557
Authors:
Takaishi, K
Miyamoto, M
Seki, T
Miyamoto, H
Morino, A
Shikii, K
Hidaka, M
Ikeda, H
Yamaguchi, K
Citation: K. Takaishi et al., Crystal structures and physical properties of tris-(2,3-epoxypropyl)isocyanate, ANAL SCI, 15(12), 1999, pp. 1285-1286
Authors:
Mukai, H
Watanabe, S
Tsuchida, K
Morino, A
Citation: H. Mukai et al., Pharmacokinetics of NS-49, a phenethylamine class alpha(1A)-adrenoceptor agonist, at therapeutic doses in several animal species and interspecies scaling of its pharmacokinetic parameters, INT J PHARM, 186(2), 1999, pp. 215-222
Authors:
Mukai, H
Morino, A
Citation: H. Mukai et A. Morino, Effects of renal insufficiency and aging on the pharmacokinetics of a phenethylamine class alpha(1A)-adrenoceptor agonist NS-49, INT J PHARM, 185(1), 1999, pp. 37-43
Authors:
Mukai, H
Morino, A
Citation: H. Mukai et A. Morino, Renal excretion mechanism of NS-49, a phenethylamine class alpha(1A)-adrenoceptor agonist, BIOPHARM DR, 20(4), 1999, pp. 207-215
Authors:
Nakamura, A
Hirota, T
Morino, A
Imaoka, S
Funae, Y
Yamamoto, Y
Tasaki, T
Masuda, M
Kazusaka, A
Fujita, S
Citation: A. Nakamura et al., Cytochrome P450 isoforms responsible for the N-deethylation and cyclohexane-hydroxylation of NS-21, XENOBIOTICA, 29(3), 1999, pp. 243-252
Authors:
Sho, Y
Ishiodori, T
Oketani, M
Kubozono, O
Nakamura, A
Takeuchi, A
Morino, A
Arima, T
Citation: Y. Sho et al., Effects of urinary metabolites of etodolac on diagnostic tests of bilirubin in urine, ARZNEI-FOR, 49(7), 1999, pp. 572-576
Authors:
Mukai, H
Watanabe, S
Morino, A
Citation: H. Mukai et al., Pharmacokinetics of NS-49, a phenethylamine class alpha(1A)-adrenoceptor agonist - 3rd communication: Metabolism in rats, rabbits, dogs and monkeys, and effects on hepatic drug-metabolizing enzyme activities in rats after repeated administration, ARZNEI-FOR, 49(7), 1999, pp. 612-617
Authors:
Mukai, H
Watanabe, S
Morino, A
Citation: H. Mukai et al., Pharmacokinetics of NS-49, a phenethylamine class alpha(1A)-adrenoceptor agonist - 2nd communication: Absorption and excretion in rabbits, dogs and monkeys after a single administration of C-14-NS-49, ARZNEI-FOR, 49(6), 1999, pp. 527-532
Authors:
Mukai, H
Watanabe, S
Morino, A
Citation: H. Mukai et al., Pharmacokinetics of NS-49, a phenethylamine class alpha(1A)-adrenoceptor agonist - 1st communication: Absorption and excretion in rats after a singleadministration of C-14-NS-49, ARZNEI-FOR, 49(5), 1999, pp. 434-440
Authors:
Mukai, H
Sugimoto, T
Ago, M
Morino, A
Takaichi, M
Ogawa, Y
Seki, H
Matsuura, C
Esumi, Y
Citation: H. Mukai et al., Pharmacokinetics of NS-105, a novel cognition enhancer - 2nd communication: Distribution and transfer into fetus and milk after single administration, and effects of repeated administration on pharmacokinetics and hepatic drug-metabolizing enzyme activities in rats, ARZNEI-FOR, 49(12), 1999, pp. 977-985
Authors:
Mukai, H
Sugimoto, T
Ago, M
Morino, A
Citation: H. Mukai et al., Pharmacokinetics of NS-105, a novel cognition enhancer 1st communication: Absorption, metabolism and excretion in rats, dogs and monkeys after singleadministration of C-14-NS-105, ARZNEI-FOR, 49(11), 1999, pp. 881-890
Risultati:
1-13
|